Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Ring Opening Cyclization. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel 4-step synthesis of N-alkyl-3-piperidones from cyclopropyl methyl ketone. High yield, scalable process for pharmaceutical intermediates avoiding column chromatography.
Patent CN1390210A details a novel route to oxazoline intermediates for HIV drugs. Offers improved yield and fewer steps for pharmaceutical manufacturing.
Advanced synthesis of Ethyl (R)-4-Cyano-3-Hydroxybutyrate via epoxide intermediate. High purity >99%, scalable process for Atorvastatin manufacturing.
Patent CN1487916A details an improved method for beta-3 agonist intermediates, offering higher yields and streamlined manufacturing for reliable pharmaceutical suppliers.
Patent CN101781248B details a cost-effective NMP-based route for Azelastine intermediates. Discover high-purity synthesis methods and supply chain advantages for pharmaceutical manufacturing.
Patent CN115417783A details a novel route for oseltamivir enantiomers, offering high purity and scalable manufacturing for global antiviral supply chains.
Patent CN117700371B enables high-purity pharmaceutical intermediate production with improved yield and safety for global supply chains.